Prozac Weekly

See also: Generic Prozac

Prozac Weekly is a brand name of fluoxetine, approved by the FDA in the following formulation(s):

PROZAC WEEKLY (fluoxetine hydrochloride - capsule, delayed rel pellets; oral)

• 
  Manufacturer: LILLY
  
  Approval date: February 26, 2001
  
  Strength(s): EQ 90MG BASE ^[RLD][AB]

Has a generic version of Prozac Weekly been approved?

A generic version of Prozac Weekly has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Prozac Weekly and have been approved by the FDA:

fluoxetine hydrochloride capsule, delayed rel pellets; oral

• 
  Manufacturer: BARR
  
  Approval date: March 24, 2010
  
  Strength(s): EQ 90MG BASE ^[AB]


• 
  Manufacturer: DR REDDYS LABS LTD
  
  Approval date: March 22, 2010
  
  Strength(s): EQ 90MG BASE ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Prozac Weekly. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Fluoxetine enteric pellets and methods for their preparation and use
  Patent 5,910,319
  Issued: June 8, 1999
  Inventor(s): Anderson; Neil R. & Harrison; Roger G. & Lynch; Daniel F. & Oren; Peter L.
  Assignee(s): Eli Lilly and Company
  A superior enteric formulation of the antidepressant drug, fluoxetine, is in the form of enteric pellets of which the enteric layer comprises hydroxypropylmethylcellulose acetate succinate.
  
  Patent expiration dates:
  
  
  • May 29, 2017
    
    ✓ 
    Patent use: METHOD OF TREATING PEOPLE SUFFERING FROM DEPRESSION
  
  



• 
  Method for the treatment of CNS disorders
  Patent 5,985,322
  Issued: November 16, 1999
  Inventor(s): Anderson; Neil R. & Harrison; Roger F. & Lynch; Daniel F. & Oren; Peter L.
  Assignee(s): Eli Lilly and Company
  An improved method for the treatment of central nervous system disorders comprises treating patients with an enteric fluoxetine formulation.
  
  Patent expiration dates:
  
  
  • May 29, 2017
    
    ✓ 
    Patent use: METHOD OF TREATING PEOPLE SUFFERING FROM DEPRESSION WITHOUT AN INCREASE IN NAUSEA
  
  



• 
  Fluoxetine enteric pellets and methods for their preparation and use
  Patent RE39030
  Issued: March 21, 2006
  Inventor(s): Anderson; Neil Robert & Harrison; Roger Garrick & Lynch; Daniel Frederick & Oren; Peter Lloyd
  Assignee(s): Eli Lilly and Company
  A superior enteric formulation of the antidepressant drug, fluoxetine, is in the form of enteric pellets of which the enteric layer comprises hydroxypropylmethylcellulose acetate succinate.
  
  Patent expiration dates:
  
  
  • May 29, 2017
    
    ✓ 
    Patent use: METHOD OF TREATING PEOPLE SUFFERING FROM DEPRESSION
    ✓ 
    Drug product
  
  
  
  • May 29, 2017
    
    ✓ 
    Patent use: METHOD OF TREATING PEOPLE SUFFERING FROM DEPRESSION WITHOUT AN INCREASE IN NAUSEA
    ✓ 
    Drug product
  
  

See also...

• Prozac Weekly Delayed-Release Capsules Consumer Information (Wolters Kluwer)
• Prozac Weekly Consumer Information (Cerner Multum)
• Prozac Weekly Advanced Consumer Information (Micromedex)
• Fluoxetine Consumer Information (Drugs.com)
• Fluoxetine Consumer Information (Wolters Kluwer)
• Fluoxetine Delayed-Release Capsules Consumer Information (Wolters Kluwer)
• Fluoxetine Solution Consumer Information (Wolters Kluwer)
• Fluoxetine Consumer Information (Cerner Multum)
• Alti-Fluoxetine Hydrochloride Advanced Consumer Information (Micromedex)
• Phl-Fluoxetine Advanced Consumer Information (Micromedex)
• Fluoxetine Advanced Consumer Information (Micromedex)
• Fluoxetine Hydrochloride AHFS DI Monographs (ASHP)